Therefore, a collaborative international effort needs to happen immediately, increasing tumor numbers will help us to realize and supply specific biomarkers to distinguish between INI1(+) AT/RT-like tumors and other pediatric embryonal tumors. Here, SMARCB1 is linked to embryonal neoplasm.